Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5850_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
30.08.2026
Размер:
49 Мб
Скачать
Herbs forAutoimmune Diseases
https://t.me/medicina_free
371
2.1.9 Andrographis paniculata
Andrographolide, a labdane diterpene, is the main bioactive phytoconstituent in Andrographis paniculata. Recent clini- cal reports have documented the utility and potential of andrographolide as therapeutic agent in treatment of ADs like osteoarthritis, upper respiratory diseases and MS [106
109]. Methanolic and aqueous extracts of A. paniculata or
andrographolide are reported to exhibit antioxidant and acute anti-inammatory effect in carrageenan-induced paw oedema in rodents, with free radical scavenging activity by inhibiting formation of oxygen free radicals. Suppressing the expression of major pro-inammatory genes like COX-2, IL-6, IL-8, IL-1β and iNOS is reported to be the underlying mechanism of action [67].
2.1.10 Rosmarinus ocinalis
Rosmarinus ofcinalis, Family Lamiaceae, commonly known as Rosemary, contains important active constituents like phenolic diterpenes, triterpenes and acids. Studies have reported that essential oil of Rosmarinus ofcinalis sup­presses transcription of NF-κB and the arachidonic acid pathway and thus exerts anti-inammatory effect [110]. Phenolic compounds including carnosic acid, carnosol, urso­lic acid and rosmarinic acid are shown to exhibit strong anti­oxidant activity [111].
2.1.11 Coriandrum sativum
Coriandrum sativum (Coriander) is an herbaceous annual herb belonging to the Apiaceae family. Essential oils of cori­ander are rich in monoterpenes, with potent anti-bacterial, antifungal, antidiabetic, antiseptic, anxiolytic and antioxi­dant activity. Linalool, pinene, cymene, borneol, phellan­drene and geraniol are the major constituents in seed oil and decanal, decanol, cyclodecane and dodecena in the leaves [112, 113]. In vitro studies were carried out by Foudah etal. [114] to screen anti-inammatory, antimicrobial and antioxi­dant properties of Coriandrum sativum leaves oil. Anti­inammatory activity was evaluated in terms of degree of inhibition of egg albumin and trypsin-induced casein dena­turation. C. sativum leaves oil was found to demonstrate excellent anti-inammatory and antimicrobial activity and poor antioxidant effect [114]. The phytoconstituents from coriander suppress NF-κB and MAPKs signalling pathways with consequent reduction in levels of nitrite, ROS, IL-6 and TNF-α [112].
2.1.12 Morinda citrifolia
Noni (Morinda citrifolia), family Rubiaceae, commonly known as beach mulberry or cheese fruit, is an evergreen Polynesian herb. Noni seed oil (NSO) could be a preferable option for people with excessive cholesterol and cardiovas­cular disorders because of its high concentrations of polyun­saturated fatty acids, phytosterols and tocopherols [115].
Bioactive substances with anti-cancer, anti-inammatory and antimicrobial activity have been found in noni seed extracts. Tanikawa etal. [116] have reported that M. citrifo- lia seed extract exhibits anti-inammatory effect in LPS­induced RAW 264 cells. M. citrifolia seed extract was found to be effective in reducing NO generation while having no negative effect on cell viability. It was found that the M. citri- folia seed extract produced antioxidant effect by decreasing the expression of TNF-α and iNOS.These ndings support the potential therapeutic application of M. citrifolia seed extract [116]. In another study, Lee etal. [117] have reported that noni fruit juice contains asperulosidic acid, rutin, noni­osideA, (2E,4E,7Z)-deca-2,4,7-trienoate-2-O-β-- glucopyranosyl-β--glucopyranoside and tricetin that suppress expression of NFκB p65, iNOS and COX-2 and reduce NO levels in LPS-stimulated RAW 264.7 cells [117].
2.1.13 Cymbopogon citratus
Cymbopogon citratus, family Gramineae, commonly known as lemongrass, contains aglycones as well as glycosides of avonoids with anti-inammatory and antioxidant activity [118]. C. citratus has potential as a therapeutic action for inammatory disease, particularly at the gut. Suppressing expression of iNOS and NO scavenging activity are reported to be the possible mechanism of action [119]. In vivo studies have reported antidiabetic, anxiolytic, antibacterial and anti­hypertensive in leaf extracts of C. citratus. Flavonoid glyco- sides (isoorientin, cymaroside, cassiaoccidentalin B and kurilesin A) have been reported to inhibit α-glucosidase and exert hypoglycaemic effect [120]. Borges etal. [120] reported in vitro inhibition of yeast-glucosidase by various extracts and fractions of C. citratus. Molecular docking studies of the avonoids provided proof-of-concept for the hypoglycaemic effect; the compounds were found to interact with the active sites of the enzyme via hydrogen bonding [120].
2.1.14 Ocimum gratissimum
Ocimum gratissimum L. belongs to family Lamiaceae and is a widely distributed aromatic herb in management of a range of inammatory disorders. Ajayi etal. [121] have reported in vivo anti-inammatory activity of various phenolic extracts and fractions of O. gratissimum leaves in carragenan­induced inammation rodent models. The effect was possi­bly by free radical scavenging, with rutin, quercetin, caffeic acid, rosmarinic acid, circhoric acid, sitosterol, ursolic acid, salvigenin and transferulic acid being the main phytocon­stituents involved [121].
2.1.15 Tinospora cordifolia
Tinospora cordifolia, commonly known as Guduchi, belongs to Family Menispermaceae, and is reported in Ayurveda to act as an immunomodulatory agent, improving the host abil­ity to ward off infections. The major active constituents
372
https://t.me/medicina_free
A. Mukne et al.
include alkaloids (berberine, magnoorine), glycoside (car­difolioside A, tinocordiside), steroids (β-sitosterol) and ali­phatic compounds (octacosanol, hepatocosanol) [122]. In a study by Nandan etal. [123], immunomodulatory effect and efcacy of T. cordifolia in Th17-linked ADs were evaluated. Aqueous extract of T. cordifolia was shown to suppress dif- ferentiation and proliferation of anti-CD3ε and anti-CD28­stimulated naive CD4+ T cells, with reduced production of IL-17. In silico molecular docking studies validated the nd­ings, with a cytokine-receptor signalling pathway reported as the possible mechanism [123].
3 Specic AD Conditions andHerbs
Used inTheir Management
3.1 Systemic Lupus Erythematosus
Lupus is chronic inammatory autoimmune condition with a broad spectrum of clinical implications which eventually lead to tissue damage and multiple organ failure. Fig.4 gives an overview of different types of lupus such as SLE, discoid lupus erythematosus (DLE), neonatal and drug-induced lupus [124].
SLE: Multiple organ failure and diverse array of clini­cal manifestations and production of autoantibodies against nucleic acid. DLE: Chronic cutaneous disorder. Patients with DLE get red, raised sores on the face or scalp. Neonatal Lupus (NL): At birth, babies have skin rashes, kidney problems or may have heart problems that slows down rhythm of heart. Drug-induced Lupus: Some drugs (such as hydrala­zine, procainamide and isoniazid) may induce SLE­like condition although features go away when drug administration is stopped.
Numerous immunological and cellular regulators are deployed for managing this complicated autoimmune condi­tion that is characterised by a dysregulated immune response. But a complete treatment plan for this disease is not yet available [124]. Also, the existing chemosynthetic medica­tions, such as nonsteroidal anti-inammatory drugs (NSAIDS) and corticosteroids, offer restricted therapeutic benet with severe side effects like gastrointestinal reaction, bone marrow suppression and leukopenia with recurrence or aggravation of disease after withdrawal of therapy. Additionally, the illness heterogeneity and multiple clinical manifestations are highly extensive, making it difcult to manage with a single chemical medicine [8]. Wide range of clinical manifestations associated with this chronic autoim­mune conditions are maculopapular (erythematous, elevated buttery-shaped painful lesions on cheeks), cerebrovascular (anxiety, headache, seizures, psychosis, demyelination of nerve cells, ALD), hepatic (hepatitis, hepatomegaly, hepatic aneurysm), nephron-pathological [nephritis, proteinuria, haematuria, lupus nephritis (LN)], haematological (anaemia, leukopenia, thrombocytopenia), cardiac (pericarditis, myo­cardial infarction, cardiomyopathy), pulmonary (pulmonary embolism, pneumonitis, brosis), mucocutaneous (mouth ulcers, sores in inner cheek, dry mouth and gum disease) and musculoskeletal involvement (arthritis, osteoporosis, osteo­myelitis, Raynaud’s disease) [125].
Pathogenesis of SLE is complex and involves multiple cross interactions between the various elements of innate and adaptive immunity. Various aetiological factors are involved in clinical manifestation of SLE such as person’s genetic pre­disposition [inammation triggering genes such as interferon regulatory factor (IRF), OX40L, secreted phosphoprotein 1 (SPP1), TNF alpha induced protein 3 (TNFATP3), signalling pathway gene STAT], epigenetic (histone modication and DNA methylation), hormonal components (oestrogen, pro­lactin), immunological and environmental triggers [125]. Immune tolerance to self-antigens is lost in the permissive situation associated with pro-inammatory stimuli which leads to unregulated differentiation and expression of B and
Fig. 4 Overview of different types of lupus
Herbs forAutoimmune Diseases
https://t.me/medicina_free
373
T cells, further inducing production of autoantibodies [126]. This overproduction of antibodies leads to DNA and ribonu­cleoprotein damage in healthy cells, with consequent apop­tosis [124].
3.1.1 Herbs Used forManagement ofSLE
Immunomodulatory properties have been ascribed to a wide variety of phytoconstituents and can be deployed for treat­ment of autoimmune disorders such as SLE.Alkaloids (ber­berines), lectins (tomato lectin), avonoids (quercetin), phenolic glycosides, terpenoids (azadirachtin) and saponins (ginsenoside) have been found to reduce inammatory cytokines and intracellular signalling, resulting in anti­inammatory and immunosuppressive effects [9]. Natural plant-based immunotherapies and regulators of intracellular signalling provide therapeutic alternatives with symptomatic relief by altering the cell signalling pathways and ultimately reducing release of proinammatory cytokines production and B-T cell co-stimulation [9, 126, 127]. Figure5 illustrates the phytoconstituents used as symptomatic relief providers in SLE.
3.1.1.1 Tripterygium wilfordii Hook F
Triptolide, a diterpene triepoxide, is the principal bioactive phytoconstituent in the plant TwHF, that is used in manage­ment of inammatory and autoimmune diseases [128]. Triptolide has been reported to suppress the production of proinammatory cytokines, including IL-2, IFN, IL-6 and TNF, as well as the upregulation of iNOS and COX-2 [128,
129].
Zhang etal. [130] reported a study evaluating the effect of (5R)-5-hydroxy triptolide (LLDT-8), a triptolide derivative on LN in MRL/lpr mouse model of SLE.LLDT-8 was found
to have therapeutic benet in LN by suppressing chemokine expression and inhibiting immune cell inltration in kidneys [130].
Zhang etal. [131] reported a study evaluating the neuro­protective effect of triptolide in the treatment of SLE by using microRNA-146a in B cell TLR7 signalling pathway in mice. Triptolide produced signicant reduction in levels of double-stranded DNA and IgG and also improved microRNA-146a expression, with reduced expression of TLR7 microRNA, protein levels TLR7, MyD88, p-IRAK1 and p-NF-κBp65 [131]. Similarly, Liu etal. [132] showed that the effectiveness of TwHF in combination with predni­sone for the treatment of SLE was 87.5%, signicantly higher than the rate for the control (prednisone in combina­tion with Methotrexate) [132]. More extensive safety and efcacy data for triptolide in humans needs to be generated [128].
Artemisinin
Artemisinin, a sesquiterpene lactone, is isolated from Artemisia annua and Artemisia apiaceae (sweet annie, quing hao), Family Asteraceae. Both species contain active ingre­dient artemisinin and its congeners that are widely used as antimalarial and immunosuppressive agents [133]. It has been reported by Zamani et al. [134] that sesquiterpene extracts of A. annua exerted immunosuppressive effect by lowering levels of nitric oxide in LPS-primed J774A.1 mac­rophages [134]. The essential oil of the plant’s aerial parts are reported to demonstrate appreciable antioxidant effect [135].
The use of artemisinin therapy relieved proteinuria in LN, restored blood urea nitrogen and creatinine levels, lessened pathological damage to the kidneys and decreased mortality;
Fig. 5 Phytoconstituents used as symptomatic relief providers for SLE. (Reproduced with permission from Acharya Balkrishna, MDPI Cells 2020,9(4), Published by MDPI, Year-2020)
374
https://t.me/medicina_free
A. Mukne et al.
these effects are produced by inhibition of NF-κB and regu­lation of adaptive and innate immune cells, including subsets of CD4+ T cells (Th1/Th2/Th9/Th17/Tfh/Tfr/Treg), CD8+ memory T cells, Treg cells, B cells, dendritic cells, neutro­phils, mast cells and macrophages [133].
3.2 Skin-Related Autoimmune Diseases
The body’s largest organ is the skin and accounts for about 16% of the body mass. It is essential for keeping the body protected against various infectious agents and is considered as a part of the immune system. Some of the autoimmune skin disease including atopic dermatitis, vitiligo, psoriasis, pemphigus and lupus are discussed with their respective pathophysiology and herbal therapies for their management and treatment.
3.2.1 Atopic Dermatitis/Eczema
Atopic dermatitis, often known as eczema, is a chronic relapsing inammatory skin condition characterised by impaired epidermal barrier function and hyperimmune response [136]. The complex involvement of various immu­nological elements, coupled with genetic and environmental factors, is linked to onset and progression of atopic dermati­tis [137]. The three main stages of atopic dermatitis are infantile, childhood and adulthood [138].
Filaggrin (FLG), a crucial protein in epidermis development and claudin-1 (CLDN1) and a structural component of tight junctions in epidermis, was found to have a genetic relationship with atopic dermatitis. Pro-laggrin (ProFLG), a protein that functions as a structural component of stratum corneum, is encoded by the laggrin gene [139]. ProFLG polymers are cleaved and dephosphorylated by proteases to generate FLG monomers, which are linked to the accumulation of keratin la­ments and the development of stratum corneum. The moisture and acidic pH of skin are both regulated by FLG metabolites, urocanic acid and pyrrolidine carboxylic acid [137]. The homo­zygous mutation of laggrin gene is linked to early onset and severe atopic dermatitis. The expression of proteins laggrin, keratin, transglutaminase and other intracellular proteins is downregulated, resulting in aberrant corneocyte development, decreased skin moisture and elevated skin pH.
The compromised skin barrier allows allergens and microbes to enter the skin and stimulate keratinocytes into releasing IL-1β, IL-25, IL-33, macrophage-derived chemo­kines and thymic stromal lymphopoietin (TSLP) that further activate dendritic and Langerhans cells [140]. Acute atopic dermatitis is caused by response of Th2 subset; the activated dendritic cells stimulate Th2 cells to release IL-4, IL-5, IL-13, IL-31 and IL-33 which impairs keratinocyte develop­ment, reduces antimicrobial peptide production and pro­duces burning sensation. The chronic atopic dermatitis is associated with Th1, Th22 and Th17 responses which results
in aberrant keratinocyte proliferation and thickening of epi­dermis [141143].
Current therapies for management of atopic dermatitis include emollients, calcineurin inhibitors, phosphodiester­ase- 4 inhibitors (Crisaborole) and biological agents (dupil­umab, baricitinib) [144]. Some of the plant-based therapies reported for atopic dermatitis are discussed below.
3.2.1.1 Herbs Used forManagement ofAtopic Dermatitis
Aloe vera
Aloe vera is a perennial succulent xerophyte with antioxidant and antibacterial properties [145]. Aloe vera leaf extracts with high polysaccharide content are routinely used in cos­metics and over-the-counter medications to cure sunburn, skin irritation and skin diseases like eczema. Studies were performed by Na etal. [11] to investigate the oral administra­tion of processed Aloe vera gel (PAG) containing low molec­ular weight aloe polysaccharides in treating ovalbumin (OVA)-induced atopic dermatitis in BALB/c mice. The expression of tight junction genes, including claudin-1, clau­din- 8 and zonula occludens-1 (ZO-1), was downregulated in atopic dermatitis epidermis as compared to normal epider­mis. It was found that PAG administration through oral route lowered the thickness of epidermis and suppressed both overall and OVA-specic immunoglobulin E (IgE) produc­tion. In addition, inammatory cytokines, such as IFN-γ, IL-4 and IL-17A, were suppressed and restored tight junc­tions to protect skin barrier function [11].
3.2.1.2 Pentaherbs Formula
In traditional Chinese herbal medicine, PHF, a mixture of ve herbs is used as an alternative adjunct therapy for atopic dermatitis. PHF contains Flos lonicerae, Herba menthae,
Cortex phellodendri, Cortex moutan and Rhizoma atractylo­dis in a 2:1:2:2:2 w/w ratio. Tsang etal. [12] investigated the
effectiveness of PHF using an invivo mouse model with oxazolone (OXA)-mediated dermatitis. Additionally, the active components of PHF water extract were isolated and their in vitro anti-inammatory effects were evaluated on pruritogenic cytokine IL-31 and IL-33-activated human eosinophils and dermal broblasts. In this study, PHF ther­apy either orally or topically signicantly decreased ear swelling, epidermis thickness, eosinophil inltration in epi­dermal and dermal layers, and the levels of serum IL-12in mouse OXA-mediated dermatitis. The active ingredients of PHF water extract—gallic acid, berberine and chlorogenic acid—were reported to be effective in inhibiting release of pro-inammatory cytokines (IL-6, CCL7) [12].
3.2.2 Vitiligo
Vitiligo is a chronic depigmentation disorder of skin, charac­terised by destruction and loss of melanocytes which results in non-scaly depigmented patches on the skin [13]. Systemic
Herbs forAutoimmune Diseases
https://t.me/medicina_free
375
inammation of the ears and eyes can coexist with vitiligo. The brain, eye and hairs are affected by the rarest form of vitiligo known as Vogt-Koyanagi-Harada syndrome [146]. Aetiology of vitiligo is unclear, but it is mainly due to the destruction of melanocytes; about 80% of genetic and 20% of environmental factors continue to remain the leading causes of vitiligo [13].
The inheritance of vitiligo is polygenic, including various alleles and gene loci. The HLA involved in vitiligo patients were found to be A2, DR4, DR7 and DQB1*0303. The can­didate genes involved in vitiligo are transporters linked to antigen processing protein-1 (TAP1) gene, angiotensin­converting enzyme (ACE) gene, CTLA-4 and catalase (CAT) gene [147]. The innate immune response is mediated by the genes CASP7, NLRP1 and TICAM1, while the adaptive immune response is mediated by the genes CTLA4, CD80, HLA and Foxp3; majority of the genes are immune genes, that emphasise the key role of immune system in the patho­genesis of vitiligo. A small subset of risk alleles tyrosine (TYR), Oculocutaneous albinism (OCA2) and melanocortin 1 receptor(MC1R) are solely expressed in melanocytes, implying a role for melanocytes in the onset of disease [146]. The rate-limiting steps of melanin production are catalysed by the enzyme tyrosinase, which is encoded by the TYR gene [148].
Environmental risk factors associated with vitiligo include phenolic compounds that are tyrosine analogues and inter­fere with tyrosinase enzyme and synthesis of melanin. Chemically induced depigmentation was found in skin­lightening products, hair dyes, paints, adhesives and indus­trial oil which may contain the phenolic compounds such as rhododendrol, monobenzyl ether of hydroquinone (MBEH), 4-tert-butylcatechol (4-TBC) and 4-tert-butylphenol (4-TBP) [149].
Hereditary factors, autoimmune reactions, oxidative stress and production of inammatory mediators have been linked to pathophysiology of vitiligo [148]. Melanogenesis is an energy-demanding process carried out by melanocytes that results in a pro-oxidant condition in the skin. The syn­thesis of melanin requires essential protein tyrosine-related protein 1. Tyrosine-related protein 1 interacts with the cal­nexin complex in response to oxidative stress, which reduces its stability and induces the formation of hazardous melanin intermediates. Individuals with vitiligo demon­strate modied functionality of mitochondria, that seem to be the main source of ROS [146, 148]. Overproduction of ROS triggers the unfolded protein response (UPR), which causes melanocytes to produce exosomes that carry molec­ular protein patterns associated with damage, as well as melanocyte-specic antigens, miRNAs and heat shock pro­teins [150]. Exosomes aid in their development into ef­cient antigen-presenting cells by transferring vitiligo target antigens to nearby dendritic cells. Stressed melanocytes
release CXCL12 and CCL5, which are also implicated in T cell localisation to the skin. In vitiligo lesions, CD8+ T cells release IFN-γ; IFN-γ binds to its receptor and activates the JAK/STAT pathway, as a result CXCL9 and CXCL10 are secreted in the skin. The melanocyte-specic CD8+ T cells are recruited through cognate receptors CXCR3, CXCL9 into the skin and CXCL10 increases their localisation within the epidermis which results in acceleration of inammation through a positive feedback mechanism. Melanocyte-reactive resident memory T cells are responsi­ble for maintaining established vitiligo in skin through IL-15-dependent signalling [13, 151].
The current therapies for management of vitiligo include topical corticosteroids, mini pulse oral corticosteroids, nar­row band UVB phototherapy and methotrexate, that need to be used over extended periods of time with resultant skin atrophy, acne and contact allergy. Some of the herbal thera­pies for management of vitiligo with least adverse events are discussed here.
3.2.2.1 Herbs Used forManagement ofVitiligo
Piper nigrum
Piper nigrum fruit belongs to the family Piperaceae, with reported bioactivities including antioxidant, anti­inammatory and immunomodulatory [15]. Melanocyte pro­liferation stimulants are of interest as potential treatment for vitiligo. The amides such as piperine, guineesine and piperi­cide found in P. nigrum have the ability to promote the growth of melanocytes [14, 152]. In a study by Shaee etal. [153], patients with facial vitiligo were given topical piper­ine, along with narrowband UVB (NB-UVB) irradiation which appreciably increased the incidence of re- pigmentation at 1, 2 and 3 months compared to the untreated control group [153]. Another clinical trial was performed on human sub­jects affected by vitiligo in which ointments containing pure piperine and P. nigrum fruit extract were tested and found to repigment the affected skin areas. Crude extract produced results more quickly and effectively compared to pure piper­ine [14].
Nigella sativa
Nigella sativa, family Ranunculaceae, is commonly known as black seed or black cumin [16]. N. sativa contains natural bioactive substances like alkaloids, saponins, alpha-hederin and thymoquinone, which are responsible for its wide list of therapeutic activities including analgesic, anti-inammatory, antioxidant and immunomodulatory activity. N. sativa inhib­its the enzymes elastase and myeloperoxidase and also lipid peroxidation, raising the defence against free radicals with consequent exertion of antioxidant effect [154]. Clinical tri­als were carried out by Sarac etal. [17] to examine the effec­tiveness of topical N. sativa seed oil in vitiligo patients. N. sativa-containing cream was used topically on commonly
376
https://t.me/medicina_free
A. Mukne et al.
affected areas of face, hands and genital region twice a day for 6 months. The studies reported noteworthy hyperpigmen­tation with no adverse effects [17].
strated superior activity of Oryza sativa extract in substan­tially reducing severity of psoriasis as compared to untreated skin specimens. In this study, Oryza sativa extract has been found to increase expression of anti-inammatory cytokines
3.2.3 Psoriasis
Psoriasis is a chronic inammatory autoimmune skin condi­tion that affects individuals of all age groups, involving inter­action of immune cells and epidermal keratinocytes and is characterised by excessive proliferation and inltration of immune cells [155]. The most common clinical symptoms
(IL-10 and TGF-β) and downregulation of proinammatory cytokines (IL-6, IL-8, IL-20, IL-22 and TNF-α). It was reported to decrease inammation of epidermis and extent of apoptosis through induction of caspase-3. Anthocyanins being antioxidant and anti-inammatory in nature, reduce keratinocyte proliferation [19].
include recurrent are ups of thick patches of red and inamed skin covered by aky and silver scales on the sur­face of skin, dry itchy skin, pruritis, swelling of joints and discoloration of skin. Clinically, psoriasis is divided into two groups: psoriasis with pustular and non-pustular lesions. The non-pustular type of psoriasis involves plaque, arthritis, vul­garis, inverse, guttate and erythrodermic, whereas pustular psoriasis involves impetigo herpetiformis, palmoplantar and acrodermatitis continua of hallopeau [156, 157]. Aetiology of psoriasis is not clear; interplay of genetic, epigenetic and environmental factors triggers the onset of disease. With involvement of myeloid dendritic cells, cytokines stimulate
Perilla frutescens
Various portions of Perilla frutescens have been reported to contain a diverse range of phytoconstituents like volatile oil, fatty acids, policosanols, tocopherols, phytosterols and hydrophilic compounds like phenols, avonoids and triter­penes. Xu etal. [163] analysed the effectiveness of the essen­tial oil isolated from P. frutescens stem and leaves using IMQ-induced psoriasis-like lesions in the BALB/c mice model. It has been observed that essential oil is able to reduce the levels of pro-inammatory cytokines IL-6, IL-17, IL-23 and NF-B [163].
aberrant keratinocyte growth and induction of various inammatory mediators. IL-17-producing Th cells, with innate lymphoid cells 3 (ILC3), apparently induce psoriasis
3.3 Autoimmune Addison’s Disease
rashes without T-cell/antigen interaction, in response to anti­microbial peptides secreted by activated keratinocytes and inammatory cytokines [18]. Cell signalling pathways play a major role in aetiology of psoriasis; the key regulatory path­ways involve STAT, NF-κB and MAPK signalling [158].
AAD, usually referred as primary adrenocortical insuf­ciency, is characterised by inefcacy of the adrenal cortex in synthesis of adequate amount of mineralocorticoids and vital steroidal hormones-glucocorticoids. Effective management of AAD requires continuous hormone replacement therapy.
3.2.3.1 Herbs Used forManagement ofPsoriasis
Number of medicinal plants have been reported in literature, for management and therapeutic interventions of psoriasis including Silybum marianum, Wrightia tinctoria, Curcuma
longa, Aloe vera, Angelica sinesis, Cassia tora, Capsicum annum, Smilax china and many more [159161]. Some of
the more commonly used herbs are discussed with their respective molecular mechanisms of action.
Depending on whether the condition is acute or chronic, sev­eral clinical manifestations may occur; the most frequent symptoms are exhaustion, weight loss, anorexia, nausea, vomiting, diarrhoea and salt craving. The most specic symptom is hyperpigmentation of the surfaces of the skin and mucosa, and is related to elevated levels of adrenocorti­cotropic hormone (ACTH) and melanocyte stimulating hor­mone (MSH) [164]. Melanin production is catalysed by the enzyme tyrosinase, that converts amino acid tyrosine into
Oryza sativa
Oryza sativa L. is commonly known as black rice. It has been reported by Thepthanee et al. [162] that n-butanolic
L-3,4-DOPA, which is further oxidised to form DOPA qui­nine and leads to production of melanin by free radical cou­pling pathway.
(n-BuOH) extract of Oryza sativa enriched with total avo­noids, phenolics and anthocyanins, possesses strong antimi­crobial and immunomodulatory effects. It was also shown to have strong antioxidant properties as determined by 2,2-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) and α,α-diphenyl-β-picryl hydrazyl (DPPH) radical­scavenging tests [162]. In vitro and invivo studies were per- formed by Ampawong etal. [19] on human psoriatic articial skin and imiquimod (IMQ)-induced rat psoriasis model, respectively. Both in vitro and invivo models have demon-
destruction of adrenal tissues and failure of adrenal cortex; it may occur in combination with APS1 and autoimmune poly­glandular syndrome type 2 (APS2) or isolated AADs [165]. Mutation in AIRE is thought to be the major causative factor for monogenetic autoimmune disorder APS-1 [166]. Aetiology of primary adrenocortical insufciency includes destruction of adrenal cortex, deciency of steroidogenic enzyme, impaired steroidogenesis pathway and infectious agents [167]. Congenital adrenal hyperplasia is the most fre-
Common cause of primary adrenocortical insufciency is
Herbs forAutoimmune Diseases
https://t.me/medicina_free
377
quent hereditary form of primary adrenocortical insuf­ciency caused by deciency of steroidogenic enzyme. The immune system targets enzyme 21-hydroxylase which is located in smooth endoplasmic reticulum (ER) of adrenocor­tical cells, resulting in autoimmune destruction of the adre­nal cortex, which is a hallmark of autoimmune primary adrenal insufciency. The gene CYP21A2 encodes the enzyme 21-hydroxylase, which is essential for biosynthesis of the steroidal hormones cortisol and aldosterone. Mutation of gene CYP21A2 is associated with congenital adrenal hyperplasia [168]. Patients with AAD develop autoantibod­ies against self-antigen 21-hydroxylase, which is a key indi­cator in clinical diagnosis [164]. Autoantibodies against 21-hydroxylase attack the carboxy terminal of the enzyme and consist of IgG1 isotype which can cross the placenta [169]. Studies have reported that 21-hydroxylase autoanti­bodies inhibit the activity of 21-hydroxylase enzyme invitro, but do not show inhibitory effect invivo. Though these auto­antibodies can cross the placenta, they do not cause hypoad­renalism in newborns. The pathophysiology of AAD may not be inuenced by steroidal 21-hydroxylase autoantibodies. [170].
AAD is mediated by 21-hydroxylase-specic CD8+ T cells; the cells of adrenal cortex respond to inammatory and stressful events by releasing proinammatory cytokines IL-6, IL-8, IL-18, IL-1 and TNF-α. The infections caused by Mycobacterium tuberculosis lead to cytotoxic T lymphocyte inltration that reaches adrenal glands through blood circu­lation leading to initiation of AAD. The specic epitope HLA-A2 (21-hydroxylase 342–350 amino acid) binds with specic CD8+ T lymphocytes and stimulates production of IFN-γ. The CD8+ T lymphocytes lyse the cells that express 21-hydroxylase through the production of granzyme B [170].
Hormone replacement therapy with glucocorticoids forms the mainstay for current AAD management. However, chronic administration of this therapy is linked to severe tox­icity and drug-induced autoimmunity. In AAD, hyperpig­mentation of skin is associated with stimulation of melanocyte receptors by ACTH [170]. Herbs like Curcuma
longa, Glycyrrhiza glabra, Emblica ofcinalis, Trigonella foenum graecum (fenugreek), Boswellia serrata and many
more commonly used for management of AAD are discussed below.
3.3.1 Herbs Used forManagement ofAddison’s
Disease
3.3.1.1 Glycyrrhiza glabra
Glycyrrhiza glabra, Family Fabaceae, has been used in treat­ment of mild-to-moderate adrenal insufciency. Glycyrrhizin increases the cortisol level by inhibiting the enzyme 11beta­hydroxysteroid dehydrogenase (11-HSD) which is responsi­ble for oxidation of cortisol to its inactive form cortisone
[23]. Long-term use of glycysrrhizin is associated with hyper mineralocorticoid-like effect in humans and animals. However, these effects are reversible upon withdrawal of glycyrrhizin [24]. Methlie et al. reported increased serum cortisol levels for 2.6h after consumption of G. glabra in 17 AAD patients, selected from Haukeland University Hospital’s outpatient clinic [171]. Kumari etal. [172] studied invitro tyrosinase-inhibitory activity of different concentra­tions of glabridin on B16 melanoma cells and reported concentration- dependent reduction in melanin [172].
3.3.1.2 Boswellia serrata
Boswellia serrata, Burseraceae, commonly known as Salai/ Salai guggul, has been in use for a long time in folk medi­cine to combat a variety of chronic inammatory diseases as well as in ceremonial and religious events as incense. It con­tains oleo gum resin obtained from incision made on the trunk of Boswellia tree and consists of 30–60% resin, 5–10% essential oils, and polysaccharides. These extracts contain 4 major pentacyclic triterpenic acids—11-keto-β- boswellic acid, acetyl-β-boswellic acid, β-boswellic acid and acetyl-11- keto-β-boswellic acid—and monoterpenes, diterpenes, triterpenes and tetracyclic triterpenic acids, that are reported to be responsible for inhibition of pro-inam­matory enzymes [173, 174]. Morsy etal. [173], reported a study comparing the efcacy of a host of plant steroids in interacting with glucocorticoid receptor (GR) by in silico techniques and further validation of their in vivo anti­inammatory activity in the classical cotton pellet-induced granuloma models in rats. Boswellic acid demonstrated superior interaction with GR, comparable to uticasone as well as brought in a signicant decrease in serum levels of IL-6 and TNF-α [173].
3.3.1.3 Fenugreek
Trigonella foenum graecum Linn, Fabaceae, used as dietary supplement and spice in India contains steroidal sapognins diosgenin along with lecithin, phosphates, trimethylamine, trigonelline, choline and iron and has antioxidant, hypolipid­emic, hypoglycaemic and immunomodulatory activity. Its potential role in managing various neurological disorders such as cognitive impairment, depression and neurodegen­erative disorders (PD, ALD and Huntington’s disease (HD)) is being examined [175]. Aylanc etal. [176] evaluated invitro tyrosinase-inhibitory activity of various phenolic extracts of Trigonella spruneriana BOISS and reported that its metha­nolic, ethanolic and ethyl acetate extracts showed apprecia­ble tyrosinase-inhibitory activity when compared with kojic acid [176]. Prema etal. [177], reported that fenugreek seed extract was able to inhibit the action of AChE, a crucial enzyme involved in the progression of ALD, when tested in aluminium chloride-induced experimental AD model in male albino Wistar rats [177].
378
https://t.me/medicina_free
A. Mukne et al.
3.4 Neurological Diseases
Progressive destruction and malfunction of the neurons or nerve cells are characteristics of neurodegenerative disorders with protein deterioration, oxidative stress, inammation, environmental factors, mitochondrial deciencies, family history and aberrant protein build-up in neurons listed as some of the most extensively researched causes. Neurological autoimmune diseases that cause inammation and neurode­generation of central nervous system (CNS) include MS, ALD and PD.
3.4.1 Commonly Used Herbs
forNeurodegenerative Diseases
Medicinal plants and products such as Baccopa monnieri, Withania somnifera (ashwagandha), curcumin, ginseng, jata- mansi, Shankhpushpi, guduchi, resveratrol, Ginkgo biloba, Centella asiatica and Triphala have been used to prevent or
treat neurological illnesses [178]. Some of these are dis­cussed below.
3.4.1.1 Bacopa monnieri
Bacopa monnieri, family Scrophulariaceae, commonly known as Brahmi has been applied in Ayurveda as a nervine tonic since the sixteenth Century. Brahmi contains betullic acid, bacoside A (64.28%), bacoside B (27.11%), - mannitol, stigmastanol and β-sitosterol. Bacopa monnieri contains pharmacologically active saponins (bacosides A and B, bacopide or bacopasaponins), which have sedative, anti­amnesic, anti-epileptic, anti-anxiety, anti-depressant and neuroprotective activities [179]. Its potential as anti­Parkinsonian drug is reported to be, by reducing alpha synu­clein aggregation, preventing dopaminergic neurodegeneration and restoring the lipid content in nema­todes on pharmacological Caenorhabditis elegans models of Parkinson’s [180]. Kishore etal. [181] evaluated two mar­keted drugs of Bacopa monnieri for their nootropic effect in treatment of dementia in scopolamine-induced amnesic Swiss mice models. Both the products, after 14 days of administration, were able to decrease the effect of scopol­amine and restore memory [181].
3.4.1.2 Ginkgo biloba
Ginkgo biloba, commonly referred as Living fossil [182], is well known for enhancing cerebral function [183]. Yu etal. [184] reported a study evaluating the neuroprotective effect of Ginkgo biloba extract and formulation in in vitro and invivo PD models. The extract and formulations provided neuroprotective effect in 1-methyl-4-phenyl-1,2,3,6­tetrahydropyridine (MPTP)-induced damage in human neu­roblastoma SH-SY5Y cells by blocking the apoptotic cycle. Similar results were observed in MPTP-induced PD mice models, with reduced neuronal damage and improved motor
coordination. Improved locomotion in 6-hydroxydopamine (6-OHDA)-induced PD in zebra sh was reported, possibly due to inhibition of dopaminergic loss, as demonstrated by Tyrosine hydroxylase (TH) immunostaining [184]. In a pilot study reported by Rapp etal. [185], 189 patients suffering from ALD were divided into groups that received either G. biloba extracts or donepezil, over a period of 12 months. The patients who received G. biloba extracts showed comparable effect on cognitive symptoms, as those that were adminis­tered donepezil, but with much fewer adverse events and improved safety prole [185].
3.4.1.3 Centella asiatica
Centella asiatica (Gotu kola) is a conventional herb widely used in Ayurveda for memory and cognitive function improvement. Centella contains several pentacyclic triterpe­noids, including asiaticoside, brahmoside and madecassic acid that shows anti-inammatory, neuroprotective and mitoprotective effects [186188]. Haz etal. [188] reported a comprehensive study evaluating the neuroprotective effect of ethanolic extract of C. asiatica by a series of invitro and in vivo tests. The extract produced signicant reduction in acetylcholinesterase activity in SH-SY5Y cells. A similar concentration-dependent reduction in levels of ROS and GSH and the pro-inammatory cytokines—PGE2 and TNF-α—were observed in LPS-stimulated RAW 264.7 cells. These invitro ndings were validated in vivo in the LPS­induced Sprague Dawley rats model for neuroinammation [188]. Fujimori etal. reported a study evaluating the neuro­protective effect of Centella asiatica and its component ara- liadiol against damage induced by ER stressors—glutamate and tunicamycin—in murine hippocampal cells (HT22). Suppression of cell death by inhibiting ROS production and phosphorylation of PERK (one of the main transducers of ER stress), respectively, was found to be the mechanism involved. They further validated this invivo, in mice with scopolamine-induced amnesia, with improved cognitive function in treated mice [189]. Gray etal. [190] reported the physiological mechanism for the improved cognitive func­tion demonstrated by C. asiatica. They evaluated the neuro­protective effect of C. asiatica on amyloid-β (Aβ) exposure in the mouse model of ALD.Water extract of C. asiatica increased arborisation in the dendrites and spine densities in the neurons and prevented loss of spines caused by Aβ expo- sure [190].
3.4.1.4 Nardostachys jatamansi
Nardostachys jatamansi is a blooming, rare and most ancient species within the family Valerianaceae. It has anti­inammatory, antioxidative, cardioprotective, hepatoprotec­tive, hypolipidemic and antifungal activity. The major chemical constituents include crystalline acid, jatamansic acid, hydrocarbons, a poly-oxygenated crystalline solid
Herbs forAutoimmune Diseases
https://t.me/medicina_free
379
together with A-endesmol, B-eudesmol, ethanol, angelicin and 4-hydroxy thymol dimethyl ether [191]. Liu etal. [192] studied the neuroprotective effect of N. jatamansi root etha­nolic extract in both invitro cell culture system and invivo Drosophila ALD model. It was observed that N. jatamansi extract suppressed Aβ-induced cell death in SH-SY5Y cells and also reduced Aβ42-induced cell death in the brain in ies. Intake of N. jatamansi extract reduced ROS level, NO level in Aβ42-expressing ies and extracellular-signal­regulated kinase (ERK) phosphorylation. It was reported by Liu et al. that N. jatamansi exhibits neuroprotective effect against Aβ42 neurotoxicity both invivo and invitro, due to its anti-inammatory, antioxidative and ERK signalling inhibitory action [192].
Shankhpushpi
In Ayurveda, the plant Shankhpushpi (Convolvulus pluricau­lis), which is categorised under Medhya Rasayana, is utilised
as the greatest brain tonic medication. The major bioactive components of C. pluricaulis are the glycosides, steroids (stigmasterol and betulinic acid), avonoids (β-carotene and chlorogenic acid), alkaloids and coumarins (scopoletin). C. pluricaulis possesses anti-inammatory, anti-oxidative, analgesic and tranquilising properties. Since ancient times, it has been used to treat chronic bronchitis, asthma, hyperten­sion and for fever reduction [193, 194]. In Indian traditional medicine, four sources of Shankhpushpi reported are
Canscora decussata Schult., Clitorea ternatea Linn., Convolvulus pluricaulis and Evolvulus alsinoides Linn. In
vitro and invivo studies on β-amyloid-induced neurotoxicity in neuroblastoma cell lines, Neuro-2a and scopolamine­induced amnesia in male Sprague Dawley rats, respectively, were conducted by Sethiya etal. [195] to examine the neuro­pharmacological effects of methanolic extracts of all four species of Shankhpushpi. Inhibition of the enzymes acetyl­cholinesterase and 5-lipoxygenase and antioxidant activity were the other invitro studies conducted by them. Evolvulus alsinoides Linn. demonstrated superior invitro and invivo neuropharmacological effects in comparison to the other three varieties of Shankhpushpi suggesting that it had the potential to be developed as therapeutic agents against neu­rodegenerative diseases [195].
Triphala
Triphala is a widely used and extremely effective polyherbal Ayurvedic medication classied as Tridoshaic rasayana made from the fruits of the plants Terminalia bellerica (Bibhitaki), Terminalia chebula (Haritaki) and Emblica of- cinalis (Amalaki). It is a key component of digestive system and other rejuvenative therapies. In streptozotocin-induced diabetes rat models, triphala treatment was reported to sup­press the progression of associated neuropathy, with signi­cantly increased motor nerve conduction velocity and
decreased thermal and mechanical hyperalgesia as well as mechanical allodynia, possibly due to elevated levels of Nerve growth factor (NGF), particularly in the sciatic nerves. TGF-1, TNF and IL-1 levels in the circulation were mark­edly reduced by this therapy. Histopathological investigation conrmed Triphala churna’s neuroprotective properties [196]. In another study, it has been reported that triphala has potential as a neuroprotective agent, with activity against oxidative stress, both in SH-SY5Y cells and zebra shes [197].
3.4.2 Multiple Sclerosis
MS is a chronic inammatory disease of the CNS, catego­rised by demyelination, degeneration of neurons and loss of axons, giving rise to localised lesions in the grey and white matter of the brain. Aetiology of MS is not clear and includes immunological, genetic and environmental factors. The fac­tors that trigger onset of MS include gut microbiota, smok­ing, deciency of vitamin D, obesity, infections and heavy metals (cadmium, lead) in food [198]. The clinical symp­toms associated with MS include dysarthria, nystagmus, tremor, disturbance of vision, sensory and motor neurons. Individuals with genetic predisposition to environmental fac­tors and variables are at greater risk of developing MS.Infections associated with human herpes virus-6 (HHV-
6), Epstein-Barr virus (EBV) and Chlamydia pneumoniae are responsible for increasing risk of developing MS [199]. The fundamental mechanisms behind MS remain largely unknown, which has resulted in disease classications based on natural history and an insufcient knowledge of the pro­cesses responsible for its origin and progression. MS is clas­sied in major types, namely relapsing remitting MS (RRMS) type in which exacerbation occurs recurrently with partial or complete recovery. About 85% of MS patients are found to be affected with RRMS [200]. Secondary progres­sive MS (SPMS) is the type in which there is gradual wors­ening of clinical disability; about 50% of patients with RRMS enter SPMS.Primary progressive MS (PPMS) is a type in which there is gradual worsening of neurologic func­tion. Microorganisms have the ability to elicit anti­inammatory and proinammatory responses, activate the innate immune system and mimic myelin proteins in the CNS.Gene responsible for higher risk of developing MS is human lymphocyte antigen DRB1*15:01 allele (HLA­DRB1*15:01) [200].
Pathogenesis of MS involves interaction between immune cells and neurons. It is believed that failure of central and peripheral immune tolerance mechanisms triggers autoim­mune activation of T cells [201]; the presence of T cells in CNS plays an important role in pathogenesis of MS. The activated autoreactive T cells enter CNS through impaired blood brain barrier (BBB) and create an inammatory envi­ronment that leads to death of oligodendrocytes which ulti-
380
https://t.me/medicina_free
A. Mukne et al.
mately leads to degeneration of myelin sheath and loss of neuron. The subsets of helper T cells, Th1 and Th17 release proinammatory cytokines IFN-γ and IL-17, respectively. The oligodendrocytes are directly killed by cytokine IFN-γ whereas IL-17 expresses TNF-α and IL-6 [202204]. Granzyme B can be released by CD4+ and CD8+ T cells that express IL-17 and destroy neurons by binding to the gluta­mate receptor (GluR3). The inammatory response triggered by IL-17 and TNF-α is associated with degeneration of neu­rons by activation of transcriptional factors STAT-1 and NF-κB [205]. The inammatory response is triggered when IL-17 produces inducible NO synthase, which eventually results in an increase in NO in various cells [206]. Alteration of gut microbiota, and increased exosomal protein and intra­cellular miRNA prole are the factors responsible for altera­tion in function of Treg cell in MS [207]. Activation of microglia with involvement of T and B cells, release ROS and nitrogen species which leads to mitochondrial damage and gene deletion in MS lesions with persistent demyelin­ation or neurodegeneration [207, 208].
Currently, there are no treatments to treat MS completely; however, a number of therapeutic options are available to moderate the disease progression and provide characteristic mitigation. There are a number of phytoconstituents that are reported to decrease demyelination, these include avonoids (quercetin, hesperidin, luteolin and icariin) [209]. Some of the herbs with potential to manage MS are discussed below.
3.4.2.1 Artemisia dracunculus
Artemisia dracunculus L., family Asteraceae, is an everlast­ing herb containing essential oils, avonoids, coumarins, phenylpropanoids and tannins which are attributed with anti­inammatory and antioxidant properties [26]. Since aetiol­ogy of MS is unclear, therapies focus on reducing inammation and restoring myelin through the repair of damaged tissue. The inhibition of Th1 and Th17 cell cyto­kines by the aqueous extract of A. dracunculus was studied in the experimental autoimmune encephalitis (EAE) model by Safari etal. [210]. Immunisation with myelin oligoden­drocyte glycoprotein (MOG35-55) and Complete Ferund’s adjuvant (CFA) was done to induce EAE in C57BL/6 mice. A. dracunculus was found to markedly reduce expression of pro-inammatory cytokines IL-1, TNF-α, IL-6 and IFN-γ through inhibition of NF-κB signalling pathway. A. dracun- culus extracts in EAE mice appear to modify immunological responses and raise serum antioxidant levels, which reduces demyelination [210].
3.4.2.2 Silybum marianum
Silybum marianum belongs to the family Asteraceae and is commonly known as milk thistle. Silymarin, a complex mix­ture of avonolignans, avonoids (taxifolin, quercetin) and
polyphenolic compounds, is reported to have excellent hepato- protective and antioxidant properties [211]. In vitro study performed by Shariati etal. [212] suggested that sily­marin might present a potential therapeutic option for MS.In this study, the effect of silymarin on the proliferation and activation of Treg cells isolated from newly diagnosed MS patients was investigated. Expression of STAT5, JAK3 and Foxp3 genes and release of IL-10in IFN-β treated RRMS patients were also examined. Silymarin promoted prolifera­tion of Treg cells and the expression of genes STAT5, JAK3 and Foxp3 was improved by silymarin [212].
3.4.3 Alzheimer’s Disease
ALD is the most common reason for memory loss in older adults. It is a slowly progressing, complex neurodegenerative disorder that impacts numerous regions of the cerebral cor­tex and hippocampus, and is characterised by neuritic plaques and neurobrillary tangles due to accumulation of insoluble forms of amyloid-beta peptide (Aβ) in the extracel­lular spaces and blood vessels of the affected areas of the brain [213, 214]. The major clinical manifestations are cog­nitive impairment, behavioural changes, depression, halluci­nation and dementia. The basic aetiology of ALD is destruction of nerves, especially cholinergic nerves. The risk factors associated with ALD include genetic predisposition to environmental triggers such as smoking, infectious agents and toxins. ALD is classied into two types based on the age groups: affected-sporadic and familial ALD.Sporadic ALD affects individuals above 65 years of age and familial ALD affects individuals between 30 and 65 years age group. The risk factors associated with sporadic ALD include the pres­ence of the epsilon-4 (ε4) allele of the APOE gene (APOEε4) and the mutations in the APP or presenilin 1 (PSEN1); prese­nilin 2 (PSEN2) genes are the causative factors for familial ALD [214217].
APP exists as a transmembrane protein which helps in growth and repair of neurons, and commonly occurs in neu­ronal synapses. In normal non-amyloidogenic processing, APP is degraded by enzyme α-secretase followed by β-secretase that forms soluble fragments and is cleared from the brain. The enzymes α-secretase and β-secretase cleave APP during aberrant amyloidogenic processing, producing insoluble amyloid beta 42 fragments. Extracellular plaques build up as a result of impaired removal of the insoluble frag­ments from interstices of the brain. In neural axons, the tau protein serves as a stabilising protein for microtubules. Evidence suggests that elevated levels of ferrous (Fe2+) chlo­ride in neurons leads to aberrant phosphorylation of tau pro­tein causing microtubule instability and formation of neurobrillary tangles eventually inducing neurodegenera­tion changes [218]. Accumulation of these pathogenic pro­teins and free radicals causes mitochondrial damage,